Related Experiment Video
Updated: Aug 24, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Ask the Experts: An International Consensus on Managing Post-Infectious Olfactory Dysfunction Including COVID-19
Sohaib Mallick1, Javier Ash1, Alfred Addison1
1Mid Essex Foundation Trust, Court Road, Broomfield, Chelmsford, CM1 7ET UK.
Post-infectious olfactory dysfunction (PIOD) management focuses on olfactory training as the primary treatment. Systemic corticosteroids are not recommended due to insufficient evidence for treating PIOD.
Area of Science:
- Neurology
- Otolaryngology
- Infectious Diseases
Background:
- Post-infectious olfactory dysfunction (PIOD) is a common sequela of viral infections, including COVID-19.
- Persistent PIOD is associated with reduced frontal lobe perfusion.
Purpose of the Study:
- To review current understanding of PIOD.
- To establish a consensus on evidence-based management strategies for PIOD.
Main Methods:
- Critical review of available management options for PIOD.
- Evidence-based approach to consensus building.
Main Results:
- Olfactory training is identified as the first-line management for PIOD.
- Systemic corticosteroids lack strong evidence for PIOD treatment and are not recommended.
Conclusions:
- Olfactory training is the most recommended management for PIOD.
- Further research is needed to clarify the role of other interventions.
More Related Videos
Related Concept Videos
Olfactory Receptors: Location and Structure
Physiology of Smell and Olfactory Pathway
The olfactory...
Olfaction
The olfactory receptors are embedded in the cilia of the...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids
Tonsillitis II: Management

